Deferrals Flashcards

1
Q

Finasteride (eg Proscar, Procpecia)

A

1 month

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Isotretinoin (eg Absorica, Accutane, Amnesteem, Claravis, Myorisan, Sotret, Zenatane)

A

1 month

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Dutasteride (eg Avodart, Jaylyn)

A

6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Acitretin (eg Soriatane)

A

3 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Etrtinate (eg Tegison)

A

Permanent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Bovine insulin manufactured in the UK

A

Idefinite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Aspirin, aspirin-containing medications, piroxicam (eg Feldene)

A

2 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Clopidogrel (eg Plavix), Ticlopidine (eg Ticlid), and Vorapaxar (eg Zontivity)

A

14 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Prasugrel (Effient) and ticagrelor (Brilinta)

A

7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Warfarin (eg Coumadin, Warfilone, Jantoven)

A

7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Heparin

A

7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Direct thrombin inhibitors (eg Dabigatran)

A

2 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Direct Xa inhibitors (eg Rivaroxaban)

A

2 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Receipt of Hepatitis B Immune Globulin

A

12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Family history of Creutzfeldt-Jakob disease (CJD)

A

Indefinite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pregnancy

A

6 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Receipt of allogeneic dura mater or pituitary growth hormone of human origin

A

Permanent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Receipt of blood, components, or human tissue

A

12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Receipt of any cells, tissues, or organs from a nonhuman animal source

A

Permanent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Receipt of toxoids, or synthetic or killed viral, bacterial or rickettsial vaccines if donor is symptom-free and afebrile

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Anthrax vaccine

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Cholera vaccine

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Diphtheria vaccine

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Hep A vaccine

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Hep B vaccine

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Influenza vaccine

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Lyme disease vaccine

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Parathyphoid vaccine

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Plague

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Pertussis vaccine

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Pneumococcal palysaccharide vaccine

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Polio (Salk/injection) vaccine

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Rabies vaccine

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Rocky Mountain spotted fever vaccine

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Tetanus vaccine

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Typhoid (by injection) vaccine

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

recombinant vaccine

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

HPV vaccine (recombinant)

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

intranasal live attenuated flu vaccine

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Measles (rubeola) vaccine

A

2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Mumps vaccine

A

2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Polio (Sabin/oral) vaccine

A

2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Thphoid (oral) vaccine

A

2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Yellow fever vaccine

A

2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

German measles (rubella) vaccine

A

4 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Chicken pox/shingles (varicella zoster) vaccine

A

4 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Small pox vaccine without complications

A

until vaccination scab falls off, or 21 days, whichever is longer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Small pox vaccine with complications

A

Deferral for 14 days after complete resolution of severe complications.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

unlicensed vaccine

A

12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Confirmed positive for HBsAg

A

Permanent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Repeatedly reactive test for anti-HBc on more than one occasion

A

Indefinite

52
Q

Positive HBV NAT result

A

Indefinite

53
Q

Repeatedly reactive test for anti-HTLV

A

Indefinite

54
Q

Present or past clinical or laboratory evidence of infection with HIV, HCV, HTLV, or T. cruzi

A

Indefinite

55
Q

Babesiosis

A

Indefinite

56
Q

Evidence or obvious stigmata of parenteral drug use

A

Indefinite

57
Q

Use of a needle to administer nonprescription drugs

A

Indefinite

58
Q

Mucous membrane exposure to blood

A

12 months

59
Q

Nonsterile skin penetration with instruments or equipment contaminated with blood or body fluids other than the donor’s own.

A

12 months

60
Q

Tattoos or permanent make-up unless applied by a state-regulated entity with sterile needles and ink that has not been reused

A

12 months

61
Q

Sexual contact or lived with individual who has acute or chronic Hep B

A

12 months

62
Q

Sexual contact or lived with individual who has symptomatic Hep C

A

12 months

63
Q

Sexual contact with an individual with HIV infection or at high risk of HIV infection

A

12 months

64
Q

Incarceration in a correctional institution (including juvenile detention, lockup, jail, or prison) for more than 72 consecutive hours

A

12 months

65
Q

Syphilis or gonorrhea

A

12 months (must have completed treatment)

66
Q

West Nile Virus

A

120 days following diagnosis or onset of illness, whichever is later

67
Q

Diagnosis of malaria

A

3 years after becoming asymptomatic

68
Q

Individuals who have lived longer than 5 consecutive years in countries considered malaria-endemic

A

3 years after departure from malaria endemic - country

69
Q

Individuals who have traveled to an area where malaria is endemic

A

12 months after departure from malaria endemic - country

70
Q

Residence in the U.K. for 3 months or more, between 1980 and 1996

A

Indefinite

71
Q

Military personnel (current and former), and their dependents, who spent time in military bases in northern Europe (1980-1990) for 6 months or more.

A

Indefinite

72
Q

Military personnel (current and former), and their dependents, who spent time in military bases in southern Europe (1980-1996) for 6 months or more.

A

Indefinite

73
Q

Donors who lived in France for 5 years or more, between 1980 and the present

A

Indefinite

74
Q

Donors who received a transfusion in the U.K. between 1980 and the present

A

Indefinite

75
Q

Blood donors who lived in Europe for 5 years or more, between 1980 and the present

A

Indefinite

76
Q

Donor who has visited a malaria-endemic area, who is a prior resident of a malaria-endemic country (5 years), and who has been a resident of non-endemic countries for less than 3 consecutive years.

A

3 years

77
Q

Donor who is a prior resident of a malaria-endemic country returns to malaria-endemic area after residence for 3 years consecutively in non-endemic countries

A

1 year

78
Q

Hepatitis diagnosed after age 11

A

Indefinite

79
Q

Double/triplet platelet apheresis

A

7 days

80
Q

Clotting factor concentrates in hemophiliacs

A

Indefinite

81
Q

Factors in nonhemophiliacs

A

1 year

82
Q

Residents of non-endemic countries with travel to endemic area from >24hrs and less than 5 years

A

1 year

83
Q

Residents of non-endemic countries with travel to endemic country but not endemic area for >24 hrs

A

none

84
Q

Previous residents of endemic countries with travel to endemic area ( prior resident of endemic country

A

3 years (if asymptomatic)

85
Q

Previous residents of endemic countries with travel to endemic area ( prior resident of endemic country >3 years after leaving)

A

1 year (if asymptomatic)

86
Q

Non-routine dental work

A

72 hrs

87
Q

Piroxicam (Feldene)

A

48 hrs

88
Q

Frequent plasmapheresis donors need to have protein or SPEP performed every…

A

4 months

89
Q

Frequent plasmapheresis donors must have blood loss less than _____/wk and less than ____/8 wks

A

25/200

90
Q

Positive crossmatch with negative screen (3)

A
  1. ABO incompatibilty
  2. Antibodies to low incidence antigens
  3. Positive donor DAT
91
Q

+NAT, RR HBsAg/confirmed, NR Anti-HBc

A

Permanently deferred

92
Q

+NAT, RR HBsAg/confirmed, RR Anti-HBc

A

Permanently deferred

93
Q

+NAT, RR HBsAg/not confirmed, RR Anti-HBc

A

Permanently deferred

94
Q

+NAT, NR HBsAg, RR Anti-HBc

A

Indefinitely deferred, may be eligible for re-entry in 8 wks

95
Q

+NAT, NR HBsAg, NR Anti-HBc

A

Indefinitely deferred, may be eligible for re-entry in 8 wks

96
Q

+NAT, RR HBsAg/not confirmed, NR Anti-HBc

A

Indefinitely deferred, may be eligible for re-entry in 8 wks

97
Q

Anti-HCV window period

A

70-80 days

98
Q

HCV NAT window period

A

7 days

99
Q

Anti-HIV 1,2 window period

A

20 days

100
Q

HIV-1 NAT window period

A

9-10 days

101
Q

If anti-HIV 1,2 +, then must do

A

Anti-HIV-2

102
Q

WNV deferral (3)

A
  1. 28 days from symptom onset
  2. 14 days after symptoms resolved
  3. 120 days from positive test.
103
Q

CMV infects which cells

A

monocytes

104
Q

RR anti-HIV, +HIV NAT

A

permanent deferral

105
Q

RR anti-HIV, WB neg/indeterm, + NR HIV NAT

A

indefinite deferral (my try re-entry in 8 weeks)

106
Q

RR anti-HIV, +WB

A

permanent deferral

107
Q

NR anti-HIV, +HIV NAT

A

indefinite deferral (my try re-entry in 8 weeks)

108
Q

RR anti-HCV, + HCV NAT

A

permanent deferral

109
Q

RR anti-HCV, + RR anti-HCV (different platform) OR +NAT

A

permanent deferral

110
Q

NR anti-HCV, +HCV NAT

A

indefinite deferral (my try re-entry in 6 months)

111
Q

RR anti-HBc x 1

A

No deferral

112
Q

RR anti-HBc x 2

A

permanent deferral

113
Q

RR anti-HBc, RR HBsAg

A

permanent deferral

114
Q

RR HBsAg, confirmed neutralization

A

permanent deferral

115
Q

RR HBsAg, nonconfirmed neutralization

A

retest in >8 weeks

116
Q

+ HBV NAT, RR HBsAg/confirmed

A

permanent deferral

117
Q

DTI and Xa inhibitors

A

1 week (2 days)

118
Q

Interval between transfusion and measles/varicella vaccine: washed RBC

A

none

119
Q

Interval between transfusion and measles/varicella vaccine: Adenine saline RBC

A

3 months

120
Q

Interval between transfusion and measles/varicella vaccine: pRBC

A

6 months

121
Q

Interval between transfusion and measles/varicella vaccine: whole blood

A

6 months

122
Q

Interval between transfusion and measles/varicella vaccine: plasma/platelets

A

7 months

123
Q

Cell saver storage temp and shelf life

A

RT - 4 hr

1-6C - 24 hr

124
Q

Shed blood/post-salvage blood

A

6 hrs

125
Q

Leishmaniasis

A

12 months after travel to Iraq

126
Q

HBV vaccine

A

21 days